PDF herunterladen
Semin Neurol
DOI: 10.1055/s-0044-1791499
Review Article

Top 10 Clinical Pearls in Vasculitic Neuropathies

Peter Pacut
1   Department of Neurology, Virginia Commonwealth University, Richmond, Virginia
,
Kelly G. Gwathmey
1   Department of Neurology, Virginia Commonwealth University, Richmond, Virginia
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Vasculitic neuropathies are a diverse group of inflammatory polyneuropathies that result from systemic vasculitis (e.g., polyarteritis nodosa, granulomatosis with polyangiitis, eosinophilic granulomatosis with polyangiitis, microscopic polyangiitis), vasculitis resulting from rheumatological disorders (e.g., rheumatoid arthritis and Sjögren's syndrome), paraneoplastic conditions, viruses, and medications. Occasionally, vasculitis is restricted to the peripheral nerves and termed nonsystemic vasculitic neuropathy. Presenting with an acute or subacute onset of painful sensory and motor deficits, ischemia to individual peripheral nerves results in the classic “mononeuritis multiplex” pattern. Over time, overlapping mononeuropathies will result in a symmetrical or asymmetrical sensorimotor axonal polyneuropathy. The diagnosis of vasculitic neuropathies relies on extensive laboratory testing, electrodiagnostic testing, and nerve and/or other tissue biopsy. Treatment consists primarily of immunosuppressant medications such as corticosteroids, cyclophosphamide, rituximab, methotrexate, or azathioprine, in addition to neuropathic pain treatments. Frequently, other specialists such as rheumatologists, pulmonologists, and nephrologists will comanage these complex patients with systemic vasculitis. Prompt recognition of these conditions is imperative, as delays in treatment may result in permanent deficits and even death.

Keywords

vasculitic neuropathy - nonsystemic vasculitic neuropathy - mononeuritis multiplex


Publikationsverlauf

Artikel online veröffentlicht:
30. September 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Blaes F. Diagnosis and therapeutic options for peripheral vasculitic neuropathy. Ther Adv Musculoskelet Dis 2015; 7 (02) 45-55
    CrossrefPubMedGoogle Scholar
  • 2 González-Gay MA, García-Porrúa C. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 1999; 78 (05) 292-308
    CrossrefPubMedGoogle Scholar
  • 3 Ozguler Y, Esatoglu SN, Hatemi G. Epidemiology of systemic vasculitis. Curr Opin Rheumatol 2024; 36 (01) 21-26
    CrossrefPubMedGoogle Scholar
  • 4 Jennette JC, Falk RJ, Bacon PA. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 5 Collins MP, Dyck PJB, Gronseth GS. et al; Peripheral Nerve Society. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 2010; 15 (03) 176-184
    CrossrefPubMedGoogle Scholar
  • 6 Hattori N, Mori K, Misu K, Koike H, Ichimura M, Sobue G. Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis. J Rheumatol 2002; 29 (07) 1408-1414
    PubMedGoogle Scholar
  • 7 Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol 2017; 13 (05) 302-316
    CrossrefPubMedGoogle Scholar
  • 8 Seo JH, Ryan HF, Claussen GC, Thomas TD, Oh SJ. Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study. Neurology 2004; 63 (05) 874-878
    CrossrefPubMedGoogle Scholar
  • 9 Kannan MA, Challa S, Kandadai RM, Uppin MS, Jabeen SA, Borgohain R. Series of paraneoplastic vasculitic neuropathy: a rare, potentially treatable neuropathy. Neurol India 2015; 63 (01) 30-34
    CrossrefPubMedGoogle Scholar
  • 10 Antoine JC, Mosnier JF, Absi L, Convers P, Honnorat J, Michel D. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 1999; 67 (01) 7-14
    CrossrefPubMedGoogle Scholar
  • 11 Blech B, Meyer M, Goodman B. et al. Vasculitis presenting as autonomic failure. Neurologist 2021; 26 (04) 117-121
    CrossrefPubMedGoogle Scholar
  • 12 Manolov V, Petrova I, Vasilev V. VEGF levels in diagnosis of vasculitic neuropathy. Clin Lab 2014; 60 (09) 1573-1577
    PubMedGoogle Scholar
  • 13 Davalos L, Watanabe M, Gallagher GW. et al. Diagnostic characteristics of nerve conduction study parameters for vasculitic neuropathy. Muscle Nerve 2023; 67 (01) 45-51
    CrossrefPubMedGoogle Scholar
  • 14 Zivković SA, Ascherman D, Lacomis D. Vasculitic neuropathy–electrodiagnostic findings and association with malignancies. Acta Neurol Scand 2007; 115 (06) 432-436
    CrossrefPubMedGoogle Scholar
  • 15 Gwathmey KG, Smith AG. Immune-mediated neuropathies. Neurol Clin 2020; 38 (03) 711-735
    CrossrefPubMedGoogle Scholar
  • 16 Olney RK. AAEM minimonograph #38: neuropathies in connective tissue disease. Muscle Nerve 1992; 15 (05) 531-542
    CrossrefPubMedGoogle Scholar
  • 17 McCluskey L, Feinberg D, Cantor C, Bird S. “Pseudo-conduction block” in vasculitic neuropathy. Muscle Nerve 1999; 22 (10) 1361-1366
    CrossrefPubMedGoogle Scholar
  • 18 Sandbrink F, Klion AD, Floeter MK. “Pseudo-conduction block” in a patient with vasculitic neuropathy. Electromyogr Clin Neurophysiol 2001; 41 (04) 195-202
    PubMedGoogle Scholar
  • 19 Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA. Nonsystemic vasculitic neuropathy. Brain 1987; 110 (Pt 4): 843-853
    CrossrefPubMedGoogle Scholar
  • 20 Bouche P, Léger JM, Travers MA, Cathala HP, Castaigne P. Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology 1986; 36 (12) 1598-1602
    CrossrefPubMedGoogle Scholar
  • 21 Goedee HS, van der Pol WL, van Asseldonk JH. et al. Nerve sonography to detect peripheral nerve involvement in vasculitis syndromes. Neurol Clin Pract 2016; 6 (04) 293-303
    CrossrefPubMedGoogle Scholar
  • 22 Hui M, Meena AK, Rajasekhar L. et al. Vasculitic neuropathy: a retrospective analysis of nerve biopsies and clinical features from a single tertiary care center. Ann Indian Acad Neurol 2019; 22 (02) 180-186
    CrossrefPubMedGoogle Scholar
  • 23 Collins MP, Periquet MI. Isolated vasculitis of the peripheral nervous system. Clin Exp Rheumatol 2008; 26 (3, suppl 49): S118-S130
    PubMedGoogle Scholar
  • 24 Collins MP, Mendell JR, Periquet MI. et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000; 55 (05) 636-643
    CrossrefPubMedGoogle Scholar
  • 25 Vital C, Vital A, Canron MH. et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst 2006; 11 (01) 20-29
    CrossrefPubMedGoogle Scholar
  • 26 Koike H, Nishi R, Ohyama K. et al. ANCA-associated vasculitic neuropathies: a review. Neurol Ther 2022; 11 (01) 21-38
    CrossrefPubMedGoogle Scholar
  • 27 Hawke SH, Davies L, Pamphlett R, Guo YP, Pollard JD, McLeod JG. Vasculitic neuropathy. A clinical and pathological study. Brain 1991; 114 (Pt 5): 2175-2190
    CrossrefPubMedGoogle Scholar
  • 28 Gwathmey KG, Burns TM, Collins MP, Dyck PJB. Vasculitic neuropathies. Lancet Neurol 2014; 13 (01) 67-82
    CrossrefPubMedGoogle Scholar
  • 29 Beachy N, Satkowiak K, Gwathmey KG. Vasculitic neuropathies. Semin Neurol 2019; 39 (05) 608-619
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 30 Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33 (01) 4-9
    CrossrefPubMedGoogle Scholar
  • 31 Comarmond C, Pagnoux C, Khellaf M. et al; French Vasculitis Study Group. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013; 65 (01) 270-281
    CrossrefPubMedGoogle Scholar
  • 32 Guillevin L, Lhote F, Gherardi R. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin 1997; 15 (04) 865-886
    CrossrefPubMedGoogle Scholar
  • 33 Gioffredi A, Maritati F, Oliva E, Buzio C. Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol 2014; 5: 549
    CrossrefPubMedGoogle Scholar
  • 34 Wilke L, Prince-Fiocco M, Fiocco GP. Microscopic polyangiitis: a large single-center series. J Clin Rheumatol 2014; 20 (04) 179-182
    CrossrefPubMedGoogle Scholar
  • 35 Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005; 252 (06) 633-641
    CrossrefPubMedGoogle Scholar
  • 36 Jones RB, Tervaert JWC, Hauser T. et al; European Vasculitis Study Group. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010; 363 (03) 211-220
    CrossrefPubMedGoogle Scholar
  • 37 Gold R, Fontana A, Zierz S. Therapy of neurological disorders in systemic vasculitis. Semin Neurol 2003; 23 (02) 207-214
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 38 Hoffman GS, Kerr GS, Leavitt RY. et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116 (06) 488-498
    CrossrefPubMedGoogle Scholar
  • 39 Caselli RJ, Daube JR, Hunder GG, Whisnant JP. Peripheral neuropathic syndromes in giant cell (temporal) arteritis. Neurology 1988; 38 (05) 685-689
    CrossrefPubMedGoogle Scholar
  • 40 Furukawa F. Cutaneous polyarteritis nodosa: an update. Ann Vasc Dis 2012; 5 (03) 282-288
    CrossrefPubMedGoogle Scholar
  • 41 Lightfoot Jr RW, Michel BA, Bloch DA. et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33 (08) 1088-1093
    CrossrefPubMedGoogle Scholar
  • 42 Henegar C, Pagnoux C, Puéchal X. et al; French Vasculitis Study Group. A paradigm of diagnostic criteria for polyarteritis nodosa: analysis of a series of 949 patients with vasculitides. Arthritis Rheum 2008; 58 (05) 1528-1538
    CrossrefPubMedGoogle Scholar
  • 43 Shiboski CH, Shiboski SC, Seror R. et al. 2016 ACR-EULAR Classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 2017; 69 (01) 35
    CrossrefPubMedGoogle Scholar
  • 44 Rist S, Sellam J, Hachulla E. et al; Club Rhumatismes et Inflammation. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: a national multicentric retrospective study. Arthritis Care Res (Hoboken) 2011; 63 (09) 1339-1344
    CrossrefPubMedGoogle Scholar
  • 45 Mekinian A, Ravaud P, Hatron PY. et al. Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis 2012; 71 (01) 84-87
    CrossrefPubMedGoogle Scholar
  • 46 Birnbaum J. Peripheral nervous system manifestations of Sjögren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 2010; 16 (05) 287-297
    CrossrefPubMedGoogle Scholar
  • 47 Shaban A, Leira EC. Neurological complications in patients with systemic lupus erythematosus. Curr Neurol Neurosci Rep 2019; 19 (12) 97
    CrossrefPubMedGoogle Scholar
  • 48 Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2011; 41 (02) 203-211
    CrossrefPubMedGoogle Scholar
  • 49 Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003; 74 (09) 1267-1271
    CrossrefPubMedGoogle Scholar
  • 50 Kolopp-Sarda MN, Miossec P. Cryoglobulins: an update on detection, mechanisms and clinical contribution. Autoimmun Rev 2018; 17 (05) 457-464
    CrossrefPubMedGoogle Scholar
  • 51 Sidana S, Rajkumar SV, Dispenzieri A. et al. Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia. Am J Hematol 2017; 92 (07) 668-673
    CrossrefPubMedGoogle Scholar
  • 52 Terrier B, Karras A, Kahn JE. et al. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine (Baltimore) 2013; 92 (02) 61-68
    CrossrefPubMedGoogle Scholar
  • 53 Bartels CM, Bridges AJ. Rheumatoid vasculitis: vanishing menace or target for new treatments?. Curr Rheumatol Rep 2010; 12 (06) 414-419
    CrossrefPubMedGoogle Scholar
  • 54 Makol A, Crowson CS, Wetter DA, Sokumbi O, Matteson EL, Warrington KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford) 2014; 53 (05) 890-899
    CrossrefPubMedGoogle Scholar
  • 55 Puéchal X, Said G, Hilliquin P. et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995; 38 (11) 1618-1629
    CrossrefPubMedGoogle Scholar
  • 56 Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006; 36 (03) 182-188
    CrossrefPubMedGoogle Scholar
  • 57 Radic M, Martinovic Kaliterna D, Radic J. Overview of vasculitis and vasculopathy in rheumatoid arthritis–something to think about. Clin Rheumatol 2013; 32 (07) 937-942
    CrossrefPubMedGoogle Scholar
  • 58 Baratta JM, Dyck PJB, Brand P. et al. Vasculitic neuropathy following exposure to minocycline. Neurol Neuroimmunol Neuroinflamm 2015; 3 (01) e180
    CrossrefPubMedGoogle Scholar
  • 59 Aladawi M, Shelly S, Dyck PJB. et al. Nitrofurantoin and minocycline-associated vasculitic neuropathy: case reports and literature review. J Clin Neuromuscul Dis 2022; 24 (02) 85-94
    CrossrefPubMedGoogle Scholar
  • 60 Baldauf MC, Kapauer M, Joerger M. et al. Pembrolizumab-associated CD8+ vasculitic mononeuritis multiplex in a patient with mesothelioma. Neurol Neuroimmunol Neuroinflamm 2021; 8 (04) e993
    CrossrefPubMedGoogle Scholar
  • 61 de Souza A, Desai PK, de Souza RJ. Acute multifocal neuropathy following cocaine inhalation. J Clin Neurosci 2017; 36: 134-136
    CrossrefPubMedGoogle Scholar
  • 62 Beniczky S, Tfelt-Hansen P, Fabricius M, Andersen KV. Multiple mononeuropathy following cocaine abuse. BMJ Case Rep 2009; 2009: bcr07.2008.0446
    CrossrefPubMedGoogle Scholar
  • 63 Roullet E, Assuerus V, Gozlan J. et al. Cytomegalovirus multifocal neuropathy in AIDS: analysis of 15 consecutive cases. Neurology 1994; 44 (11) 2174-2182
    CrossrefPubMedGoogle Scholar
  • 64 Bradley WG, Verma A. Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Neurology 1996; 47 (06) 1446-1451
    CrossrefPubMedGoogle Scholar
  • 65 Patel N, Patel N, Khan T, Patel N, Espinoza LR. HIV infection and clinical spectrum of associated vasculitides. Curr Rheumatol Rep 2011; 13 (06) 506-512
    CrossrefPubMedGoogle Scholar
  • 66 Cacoub P, Terrier B, Saadoun D. Hepatitis C virus-induced vasculitis: therapeutic options. Ann Rheum Dis 2014; 73 (01) 24-30
    CrossrefPubMedGoogle Scholar
  • 67 Murai H, Inaba S, Kira J, Yamamoto A, Ohno M, Goto I. Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange. Artif Organs 1995; 19 (04) 334-338
    CrossrefPubMedGoogle Scholar
  • 68 Scarpato S, Tirri E, Naclerio C, Moscato P, Salvati G. Plasmapheresis in cryoglobulinemic neuropathy: a clinical study. Dig Liver Dis 2007; 39 (Suppl. 01) S136-S137
    CrossrefPubMedGoogle Scholar
  • 69 Collins MP, Periquet-Collins I. Nonsystemic vasculitic neuropathy: update on diagnosis, classification, pathogenesis, and treatment. Front Neurol Neurosci 2009; 26: 26-66
    CrossrefPubMedGoogle Scholar
  • 70 Stork ACJ, van der Meulen MFG, van der Pol WL, Vrancken AFJE, Franssen H, Notermans NC. Wartenberg's migrant sensory neuritis: a prospective follow-up study. J Neurol 2010; 257 (08) 1344-1348
    CrossrefPubMedGoogle Scholar
  • 71 Collins MP, Dyck PJB, Hadden RDM. Update on classification, epidemiology, clinical phenotype and imaging of the nonsystemic vasculitic neuropathies. Curr Opin Neurol 2019; 32 (05) 684-695
    CrossrefPubMedGoogle Scholar
  • 72 van Nes SI, Vanhoutte EK, van Doorn PA. et al. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 2011; 76 (04) 337-345
    CrossrefPubMedGoogle Scholar
  • 73 Graus F, Delattre JY, Antoine JC. et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75 (08) 1135-1140
    CrossrefPubMedGoogle Scholar